Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 315-320

  Huang, Jane ^a   Kadonosono, Kazuaki ^b   Uchio, Eiichi ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

A549 cell line; Adenovirus; Epidemic keratoconjunctivitis; Ganciclovir; Nucleoside analog

Indexed keywords

EID: 84893378945     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S55284     Document Type: Article

References (37)

1. De Jong JC, Wermenbol AG, Verweij-Uijterwaal MW, et al. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J Clin Microbiol. 1999;37(12):3940-3945.
2. Wadell G, Hammarskjold ML, Winberg G, Varsanyi TM, Sundell G. Genetic variability of adenoviruses. Ann N Y Acad Sci. 1980;354(1): 16-42.
3. Walsh MP, Seto J, Jones MS, Chodosh J, Xu W, Seto D. Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen. J Clin Microbiol. 2010;48(3):991-993.
4. Kaneko H, Aoki K, Ohno S, et al. Complete genome analysis of a novel intertypic recombinant human adenovirus causing epidemic keratoconjunctivitis in Japan. J Clin Microbiol. 2011;49(2):484-490.
5. Walls T, Shankar AG, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis. 2003;3(2):79-86.
6. Zarraga AL, Kerns FT, Kitchen LW. Adenovirus pneumonia with severe sequelae in an immunocompetent adult. Clin Infect Dis. 1992;15(4): 712-713.
7. Ford E, Nelson KE, Warren E. Epidemiology of epidemic keratoconjunctivitis. Epidemiol Rev. 1987;9(2):244-261.
8. Jernigan JA, Lowry BS, Hayden FG, et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis. 1993;167(6):1307-1313.
9. Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32(9):1290-1297.
10. Gavin PJ. Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics. 2002;110(1 Pt 1):1-8.
11. Lankester AC, Heemskerk B, Claas EC, et al. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis. 2004;38(11):1521-1525.
12. de Oliveira B, Stevenson D, LaBree L, McDonnel PJ, Trousdale MD. Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res. 1996;31(3):165-172.
13. Gordon YG, Romanowski EG, Araullo-Cruz TP, et al. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor-cyclic-GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro. Antiviral Res. 1991;16(1):11-16.
14. Mentel R, Kinder M, Wegner U, Janta-Lipinski M, Matthes E. Inhibitory activity of 3′-fluoro-2′-deoxythymidine and related nucleoside analogues against adenovirus in vitro. Antiviral Res. 1997;34(3):113-119.
15. Uchio E, Fuchigami A, Kadonosono K, et al. Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol. 2007;245(9):1319-1325.
16. Hoffman JA, Shah AJ, Ross LA, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2001;7(7):388-394.
17. Trousdale MD, Nesburn AB, Willey DE, Taaid H. Efficacy of BW759 (9-[2-hydroxy-l-(hydroxymethyl)ethoxy]methyl]guanine) against herpes simplex virus type 1 keratitis in rabbits. Curr Eye Res. 1984;3(8):1007-1015.
18. Colin J. Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes. Clin Ophthalmol. 2007:1(4):441-453.
19. Smith KO, Galloway KS, Kennell WL, Ogilvie KK, Radatus BK. A new nucleoside analog, 9-[2-hydroxy-l(hydroxymethyl)ethoxy]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother. 1982;22(1):55-61.
20. Naesens L, Lenaerts L, Andrei G, et al. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother. 2005;49(3):1010-1016.
21. Trousdale MD, Goldschmidt PL, Nóbrega R. Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes. Cornea. 1994;13(5):435-439.
22. Noda M, Otagaki Y, Ikeda Y, Matsuishi T, Ogino T. Genome types of adenovirus types 19 and 37 isolated from patients with conjunctivitis in Hiroshima City. J Med Virol. 1988;26(1):15-22.
23. Miura-Ochiai R, Shimada Y, Konno T, et al. Quantitative detection and rapid identification of human adenoviruses. J Clin Microbiol. 2007;45(3):958-967.
24. Zipper H, Brunner H, Bernhagen J, Vitzthum F. Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. Nucleic Acids Res. 2004:32(12):e103.
25. Kaneko H, Suzutani T, Aoki K, et al. Epidemiological and virological features of epidemic keratoconjunctivitis due to new human adenovirus type 54 in Japan. Br J Ophthalmol. 2011;95(1):32-36.
26. O'Donnell B, McCruden EA, Desselberger U. Molecular epidemiology of adenovirus conjunctivitis in Glasgow 1981-1991. Eye (Lond). 1993;7(Pt 3 Suppl):8-14.
27. Morfin F, Dupuis-Girod S, Mundweiler S, et al. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther. 2005;10(2):225-229.
28. Uchio E, Inoue H, Kadonosono K. Antiadenoviral effects of N-chlorotaurine in vitro confirmed by quantitative polymerase chain reaction methods. Clin Ophthalmol. 2010;19(4):1325-1329.
29. Uchio E, Kimura R, Huang YH, et al. Anti-adenoviral effect of a5b1 integrin receptor ligand, GRGDSP peptide, in serotypes that cause acute keratoconjunctivitis. Ophthalmologica. 2007;221(5):326-330.
30. Fanourgiakis P, Georgala A, Vekemans M, et al. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis. 2005;40(1):199-201.
31. Ljungman P. Treatment of adenovirus infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis. 2004;23(8):583-588.
32. Hillenkamp J, Reinhard T, Ross RS, et al. The effects of cidofovir 1% with and without cyclosporin A 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology. 2002;109(5):845-850.
33. Bruno B, Gooley T, Hackman RC, Davis C, Corey L, Boeckh M. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant. 2003;9(5):341-352.
34. Wreghitt TG, Gray JJ, Ward KN, et al. Disseminated adenovirus infection after liver transplantation and its possible treatment with ganciclovir. J Infect. 1989;19(1):88-89.
35. Duggan JM, Farrehi J, Duderstadt S, Turner NJ, Fekety R. Treatment with ganciclovir of adenovirus pneumonia in a cardiac transplant patient. Am J Med. 1997;103(5):439-440.
36. Chen FE, Liang RH, Lo JY, Yuen KY, Chan TK, Peiris M. Treatment of adenovirus-associated haemorrhagic cystitis with ganciclovir. Bone Marrow Transplant. 1997;20(11):997-999.
37. Kaufman HE, Haw WH. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis. Curr Eye Res. 2012;37(7):654-660.